Summit Partners announces acquisition of Dreampath Diagnostics
Dreampath provides automated workflow systems for pathology labs, managing over 300 million samples across 500 labs in 50 countries.
See the latest news and media coverage for Summit Partners. We track all announcements, press releases, and industry mentions in real time, all in one place.
Growth-focused private equity investor
summitpartners.comLast updated
In short: Summit Partners led major growth investments in Keyfactor, Quantifind, and RunPod while achieving several notable exits and recognitions.
Dreampath provides automated workflow systems for pathology labs, managing over 300 million samples across 500 labs in 50 countries.
The global growth equity firm had invested in the company in 2025, supporting its expansion in automated pathology solutions.
The firm leads a $1B+ strategic growth investment to bolster trust infrastructure for AI and quantum computing.
The $200 million growth investment targets financial crime prevention with Graphyte Agentic Middleware.
Mike Lennon / SecurityWeek: Keyfactor, which manages billions of machine identities for more than 2,500 client organizations, raised $1B+ led by Summit Partners...
Laura Kreutzer / Wall Street Journal: Quantifind, whose AI products help banks combat financial crimes such as money laundering, raised $200M led by Summit Partners...
DUBAI, UAE/PRNewswire/ -- Odoo, a leader in open source all-in-one business software, announced a US$215M investment from growth equity investor Summit Partners. The transaction represents...
SÃO PAULO--(BUSINESS WIRE)--Celcoin, a leading company in the Banking as a Service (BaaS) financial technology market, today announced a US$125 million investment led by global...
Track Summit Partners and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Summit Partners and other trending companies.